Clinical Trial Update: A Study Comparing Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Topical Gel 0.15%;3.1%;1.2% (Taro Pharmaceuticals U.S.A., Inc.) and CABTREO Topical Gel for the Treatment of Acne Vulgaris. [Phase 1]

View source ↗

Summary

Phase 1 trial comparing a triple-combination topical gel (clindamycin phosphate, adapalene, benzoyl peroxide) with CABTREO Topical Gel for acne vulgaris has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• CABTREO Topical Gel
• Clindamycin Phosphate-Adapalene-Benzoyl Peroxide Topical Gel 0.15%/3.1%/1.2% (clindamycin phosphate; adapalene; benzoyl peroxide topical gel)

Snippet

Sponsor: Sun Pharmaceutical Industries, Inc. | Conditions: Acne Vulgaris | Phase 1 | Status: COMPLETED